Skip to main content
Erschienen in: MMW - Fortschritte der Medizin 3/2020

18.02.2020 | Akne | FORTBILDUNG . ÜBERSICHT

Ein Leitfaden für die Praxis

Akne vulgaris: Das können Sie für Betroffene tun

verfasst von: Ulrich P. Wehry, Dr. med. Norman-Philipp Hoff

Erschienen in: MMW - Fortschritte der Medizin | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Akne vulgaris ist eine harmlose, chronisch entzündliche Erkrankung der Haartalgdrüsen. Sie beginnt meist in der 2. Lebensdekade und gehört zu den häufigsten dermatologischen Erkrankungen. Betroffene haben oft einen enormen Leidensdruck. Lesen Sie hier, wie Sie Ihren Patienten Linderung verschaffen können.
Literatur
1.
2.
Zurück zum Zitat Wolkenstein P, Machovcova A, Szepietowski JC, Tennstedt D, Veraldi S, Delarue A. Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents/young adults in 7 European countries. J Eur Acad Dermatol Venereol. 2018;32:298–306. PubMedCrossRef Wolkenstein P, Machovcova A, Szepietowski JC, Tennstedt D, Veraldi S, Delarue A. Acne prevalence and associations with lifestyle: a cross-sectional online survey of adolescents/young adults in 7 European countries. J Eur Acad Dermatol Venereol. 2018;32:298–306. PubMedCrossRef
3.
Zurück zum Zitat Latter G, Grice JE, Mohammed Y, Roberts MS, Benson HAE. Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems. Pharmaceutics 2019;11. Latter G, Grice JE, Mohammed Y, Roberts MS, Benson HAE. Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems. Pharmaceutics 2019;11.
4.
Zurück zum Zitat Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001;15:541–5. PubMedCrossRef Poli F, Dreno B, Verschoore M. An epidemiological study of acne in female adults: results of a survey conducted in France. J Eur Acad Dermatol Venereol 2001;15:541–5. PubMedCrossRef
5.
Zurück zum Zitat Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a communitybased study. J Invest Dermatol. 2009;129:2136–41 PubMedCrossRef Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a communitybased study. J Invest Dermatol. 2009;129:2136–41 PubMedCrossRef
6.
Zurück zum Zitat Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49:S1–37. PubMedCrossRef Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR, Thiboutot D. Management of acne: a report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49:S1–37. PubMedCrossRef
7.
Zurück zum Zitat Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatolog Treat. 2019:1–33. Hazarika N. Acne vulgaris: new evidence in pathogenesis and future modalities of treatment. J Dermatolog Treat. 2019:1–33.
8.
Zurück zum Zitat Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to antiacne agents. Arch Dermatol Res. 2019;311:337–9. PubMedCrossRef Cong TX, Hao D, Wen X, Li XH, He G, Jiang X. From pathogenesis of acne vulgaris to antiacne agents. Arch Dermatol Res. 2019;311:337–9. PubMedCrossRef
9.
Zurück zum Zitat Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029. CrossRef Moradi Tuchayi S, Makrantonaki E, Ganceviciene R, Dessinioti C, Feldman SR, Zouboulis CC. Acne vulgaris. Nat Rev Dis Primers. 2015;1:15029. CrossRef
10.
Zurück zum Zitat Anzengruber F, Ruhwinkel K, Ghosh A, Klaghofer R, Lang UE, Navarini AA. Wide range of age of onset and low referral rates to psychiatry in a large cohort of acne excoriee at a Swiss tertiary hospital. J Dermatolog Treat. 2018;29:277–80. PubMedCrossRef Anzengruber F, Ruhwinkel K, Ghosh A, Klaghofer R, Lang UE, Navarini AA. Wide range of age of onset and low referral rates to psychiatry in a large cohort of acne excoriee at a Swiss tertiary hospital. J Dermatolog Treat. 2018;29:277–80. PubMedCrossRef
12.
Zurück zum Zitat Back O, Faergemann J, Hornqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol. 1985;12:56–61. PubMedCrossRef Back O, Faergemann J, Hornqvist R. Pityrosporum folliculitis: a common disease of the young and middle-aged. J Am Acad Dermatol. 1985;12:56–61. PubMedCrossRef
13.
Zurück zum Zitat Hsu CK, Hsu MM, Lee JY. Demodicosis: a clinicopathological study. J Am Acad Dermatol. 2009;60:453–62. PubMedCrossRef Hsu CK, Hsu MM, Lee JY. Demodicosis: a clinicopathological study. J Am Acad Dermatol. 2009;60:453–62. PubMedCrossRef
14.
Zurück zum Zitat Levy A, Feuilhade de Chauvin M, Dubertret L, Morel P, Flageul B. [Malassezia folliculitis: characteristics and therapeutic response in 26 patients]. Ann Dermatol Venereol. 2007;134:823–8. PubMedCrossRef Levy A, Feuilhade de Chauvin M, Dubertret L, Morel P, Flageul B. [Malassezia folliculitis: characteristics and therapeutic response in 26 patients]. Ann Dermatol Venereol. 2007;134:823–8. PubMedCrossRef
16.
Zurück zum Zitat Zouboulis CC, Degitz K. Androgen action on human skin — from basic research to clinical significance. Exp Dermatol. 2004;13(Suppl 4):5–10. PubMedCrossRef Zouboulis CC, Degitz K. Androgen action on human skin — from basic research to clinical significance. Exp Dermatol. 2004;13(Suppl 4):5–10. PubMedCrossRef
17.
Zurück zum Zitat Oge LK, Broussard A, Marshall MD. Acne Vulgaris: Diagnosis and Treatment. Am Fam Physician. 2019;100:475–84. PubMed Oge LK, Broussard A, Marshall MD. Acne Vulgaris: Diagnosis and Treatment. Am Fam Physician. 2019;100:475–84. PubMed
18.
Zurück zum Zitat Smith K. Mental health: a world of depression. Nature. 2014;515:181. PubMed Smith K. Mental health: a world of depression. Nature. 2014;515:181. PubMed
19.
Zurück zum Zitat Alirezai M, George SA, Coutts I, Roseeuw DI, Hachem JP, Kerrouche N, Sidou F, Soto P. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol. 2007;17:45–51. PubMed Alirezai M, George SA, Coutts I, Roseeuw DI, Hachem JP, Kerrouche N, Sidou F, Soto P. Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline. Eur J Dermatol. 2007;17:45–51. PubMed
20.
Zurück zum Zitat Adler BL, Kornmehl H, Armstrong AW. Antibiotic Resistance in Acne Treatment. JAMA Dermatol. 2017;153:810–1. PubMedCrossRef Adler BL, Kornmehl H, Armstrong AW. Antibiotic Resistance in Acne Treatment. JAMA Dermatol. 2017;153:810–1. PubMedCrossRef
21.
Zurück zum Zitat Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002;146:840–8. PubMedCrossRef Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002;146:840–8. PubMedCrossRef
22.
Zurück zum Zitat Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant?: implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003;4:813–31. PubMedCrossRef Eady AE, Cove JH, Layton AM. Is antibiotic resistance in cutaneous propionibacteria clinically relevant?: implications of resistance for acne patients and prescribers. Am J Clin Dermatol. 2003;4:813–31. PubMedCrossRef
23.
Zurück zum Zitat Fluhr JW, Gloor M, Dietz P, Hoffler U. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa. Zentralbl Bakteriol 1999;289:53–61. PubMedCrossRef Fluhr JW, Gloor M, Dietz P, Hoffler U. In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa. Zentralbl Bakteriol 1999;289:53–61. PubMedCrossRef
24.
Zurück zum Zitat Ross JI, Eady EA, Cove JH, Ratyal AH, Cunliffe WJ. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. Dermatology. 1998;196:69–70. PubMedCrossRef Ross JI, Eady EA, Cove JH, Ratyal AH, Cunliffe WJ. Resistance to erythromycin and clindamycin in cutaneous propionibacteria is associated with mutations in 23S rRNA. Dermatology. 1998;196:69–70. PubMedCrossRef
25.
Zurück zum Zitat Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A. 2005;136:117–21. PubMedCrossRef Loureiro KD, Kao KK, Jones KL, Alvarado S, Chavez C, Dick L, Felix R, Johnson D, Chambers CD. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy. Am J Med Genet A. 2005;136:117–21. PubMedCrossRef
26.
Zurück zum Zitat Brand B, Gilbert R, Baker MD, Poncet M, Greenspan A, Georgeian K, Soto P. Cumulative irritancy potential of adapalene cream 0.1% compared with adapalene gel 0.1% and several tretinoin formulations. Cutis. 2003;72:455–8. PubMed Brand B, Gilbert R, Baker MD, Poncet M, Greenspan A, Georgeian K, Soto P. Cumulative irritancy potential of adapalene cream 0.1% compared with adapalene gel 0.1% and several tretinoin formulations. Cutis. 2003;72:455–8. PubMed
27.
Zurück zum Zitat Galvin SA, Gilbert R, Baker M, Guibal F, Tuley MR. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations. Br J Dermatol. 1998;139(Suppl 52):34–40. PubMedCrossRef Galvin SA, Gilbert R, Baker M, Guibal F, Tuley MR. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations. Br J Dermatol. 1998;139(Suppl 52):34–40. PubMedCrossRef
28.
Zurück zum Zitat Alexis AF, Cook-Bolden FE, York JP. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes. J Drugs Dermatol. 2017;16:574–81. PubMed Alexis AF, Cook-Bolden FE, York JP. Adapalene/Benzoyl Peroxide Gel 0.3%/2.5%: A Safe and Effective Acne Therapy in All Skin Phototypes. J Drugs Dermatol. 2017;16:574–81. PubMed
29.
Zurück zum Zitat Kawashima M, Nagare T, Katsuramaki T. Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: A secondary publication. J Dermatol. 2017;44:635–43. PubMedPubMedCentralCrossRef Kawashima M, Nagare T, Katsuramaki T. Open-label, randomized, multicenter, phase III study to evaluate the safety and efficacy of benzoyl peroxide gel in long-term use in patients with acne vulgaris: A secondary publication. J Dermatol. 2017;44:635–43. PubMedPubMedCentralCrossRef
30.
Zurück zum Zitat Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. Am J Clin Dermatol. 2001;2:33–9. PubMedCrossRef Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. Am J Clin Dermatol. 2001;2:33–9. PubMedCrossRef
31.
Zurück zum Zitat Thiele JJ. Oxidative targets in the stratum corneum. A new basis for antioxidative strategies. Skin Pharmacol Appl Skin Physiol. 2001;14(Suppl 1):87–91. PubMedCrossRef Thiele JJ. Oxidative targets in the stratum corneum. A new basis for antioxidative strategies. Skin Pharmacol Appl Skin Physiol. 2001;14(Suppl 1):87–91. PubMedCrossRef
32.
Zurück zum Zitat Cunliffe WJ, Burke B. Benzoyl peroxide: lack of sensitization. Acta Derm Venereol. 1982;62:458–9. PubMed Cunliffe WJ, Burke B. Benzoyl peroxide: lack of sensitization. Acta Derm Venereol. 1982;62:458–9. PubMed
33.
Zurück zum Zitat Kainz JT, Berghammer G, Auer-Grumbach P, Lackner V, Perl-Convalexius S, Popa R, Wolfesberger B. Azelainsaure 20 % Creme: Auswirkung auf Lebensqualitat und Krankheitsaktivitat bei erwachsenen Patientinnen mit Acne vulgaris. J Dtsch Dermatol Ges. 2016;14:1249–60. PubMed Kainz JT, Berghammer G, Auer-Grumbach P, Lackner V, Perl-Convalexius S, Popa R, Wolfesberger B. Azelainsaure 20 % Creme: Auswirkung auf Lebensqualitat und Krankheitsaktivitat bei erwachsenen Patientinnen mit Acne vulgaris. J Dtsch Dermatol Ges. 2016;14:1249–60. PubMed
34.
Zurück zum Zitat Cunliffe WJ. Evolution of a strategy for the treatment of acne. J Am Acad Dermatol. 1987;16:591–9. PubMedCrossRef Cunliffe WJ. Evolution of a strategy for the treatment of acne. J Am Acad Dermatol. 1987;16:591–9. PubMedCrossRef
35.
Zurück zum Zitat Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol. 2001;11:538–44. PubMed Gollnick HP, Graupe K, Zaumseil RP. Comparison of combined azelaic acid cream plus oral minocycline with oral isotretinoin in severe acne. Eur J Dermatol. 2001;11:538–44. PubMed
36.
Zurück zum Zitat Greenwood R, Brummitt L, Burke B, Cunliffe WJ. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment. Br Med J. (Clin Res Ed.) 1985;291:1231–5. CrossRef Greenwood R, Brummitt L, Burke B, Cunliffe WJ. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment. Br Med J. (Clin Res Ed.) 1985;291:1231–5. CrossRef
37.
Zurück zum Zitat Mills OH, Jr., Marples RR, Kligman AM. Acne vulgaris. Oral therapy with tetracycline and topical therapy with vitamin A. Arch Dermatol.1972;106:200–3. PubMedCrossRef Mills OH, Jr., Marples RR, Kligman AM. Acne vulgaris. Oral therapy with tetracycline and topical therapy with vitamin A. Arch Dermatol.1972;106:200–3. PubMedCrossRef
38.
Zurück zum Zitat Hauk L. Acne Vulgaris: Treatment Guidelines from the AAD. Am Fam Physician. 2017;95:740–1. PubMed Hauk L. Acne Vulgaris: Treatment Guidelines from the AAD. Am Fam Physician. 2017;95:740–1. PubMed
39.
Zurück zum Zitat Ganceviciene R, Zouboulis CC. Isotretinoin: state of the art treatment for acne vulgaris. J Dtsch Dermatol Ges. 2010;8(Suppl 1):S47–59. PubMedCrossRef Ganceviciene R, Zouboulis CC. Isotretinoin: state of the art treatment for acne vulgaris. J Dtsch Dermatol Ges. 2010;8(Suppl 1):S47–59. PubMedCrossRef
40.
Zurück zum Zitat Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology. 1998;196:140–7. PubMedCrossRef Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology. 1998;196:140–7. PubMedCrossRef
41.
Zurück zum Zitat Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012:Cd004425. Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev. 2012:Cd004425.
42.
Zurück zum Zitat van Vloten WA, Sigurdsson V. Selecting an oral contraceptive agent for the treatment of acne in women. Am J Clin Dermatol. 2004;5:435–41. PubMedCrossRef van Vloten WA, Sigurdsson V. Selecting an oral contraceptive agent for the treatment of acne in women. Am J Clin Dermatol. 2004;5:435–41. PubMedCrossRef
43.
Zurück zum Zitat Scherdin U, Presto S, Rippke F, Nielsen J, Strassner M, Imadojemun A, Gartner E, Herpens A, Korting HC, Bielfeldt S. In vivo assessment of the efficacy of an innovative face care system in subjects with mild acne vulgaris. Int J Cosmet Sci. 2004;26:221–9. PubMedCrossRef Scherdin U, Presto S, Rippke F, Nielsen J, Strassner M, Imadojemun A, Gartner E, Herpens A, Korting HC, Bielfeldt S. In vivo assessment of the efficacy of an innovative face care system in subjects with mild acne vulgaris. Int J Cosmet Sci. 2004;26:221–9. PubMedCrossRef
Metadaten
Titel
Ein Leitfaden für die Praxis
Akne vulgaris: Das können Sie für Betroffene tun
verfasst von
Ulrich P. Wehry
Dr. med. Norman-Philipp Hoff
Publikationsdatum
18.02.2020
Verlag
Springer Medizin
Erschienen in
MMW - Fortschritte der Medizin / Ausgabe 3/2020
Print ISSN: 1438-3276
Elektronische ISSN: 1613-3560
DOI
https://doi.org/10.1007/s15006-020-0003-0

Weitere Artikel der Ausgabe 3/2020

MMW - Fortschritte der Medizin 3/2020 Zur Ausgabe

AKTUELLE MEDIZIN . REPORT

PTH kann jetzt substituiert werden

FORTBILDUNG . KRITISCH GELESEN

Männliche Forscher tragen gern dick auf